ResearcherKyoto Prefectural University of MedicineActive in the last 2 years
Tomohisa Takagi
Matched on ORCID iD 0000-0002-6119-4828; OpenAlex author ID A5043670524, A5139562176. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. Last author DOI 10.21873/anticanres.18260↗
- Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. Co-author DOI 10.3892/or.2020.7595↗
- The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines. Co-author DOI 10.3892/or.2017.5399↗
- The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines. Co-author DOI 10.3164/jcbn.14-8↗
- Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer. Co-author DOI 10.1002/ijc.28117↗
- Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. Co-author DOI 10.3109/02656736.2012.695428↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshito Itoh · 4 shared papers, 2014–2026 · strength 0.42
- Paper Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. DOI 10.21873/anticanres.18260↗
- Paper Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. DOI 10.3892/or.2020.7595↗
- Paper The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines. DOI 10.3892/or.2017.5399↗
- Toshifumi Doi · 2 shared papers, 2017–2026 · strength 0.29
- Takeshi Ishikawa · 5 shared papers, 2012–2020 · strength 0.24
- Paper Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. DOI 10.3892/or.2020.7595↗
- Paper The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines. DOI 10.3892/or.2017.5399↗
- Paper The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcin… DOI 10.3164/jcbn.14-8↗
- Keisuke Takemura · 1 shared paper, 2026 · strength 0.23
- Kyohei Ikeda · 1 shared paper, 2026 · strength 0.23
- N. Iwai · 1 shared paper, 2026 · strength 0.23
- Tomoki Sakakida · 1 shared paper, 2026 · strength 0.23
- Juichiro Yoshida · 1 shared paper, 2020 · strength 0.09
- Toshikazu Yoshikawa · 2 shared papers, 2012–2013 · strength 0.05
- Paper Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pa… DOI 10.1002/ijc.28117↗
- Paper Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. DOI 10.3109/02656736.2012.695428↗
- Reiko Kimura‐Tsuchiya · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.